Taken together, these results indicate that in contrast to the elevated expression of JMJD3 in MDS or T-ALL cells where it plays an oncogenic role15,21, a diminished JMJD3 expression in granulocytic subtypes of AML cells was associated with poor prognosis. Here, KDM6B is linked to myelodysplastic syndrome.